Dosing & Reconstitution Guide Subcutaneous, once or twice daily Subcutaneous Protocol (2 mL = 5 mg/mL) Frequency: Inject once or twice daily subcutaneously
Autonomic dysfunction Autonomic dysfunction in ME/CFS manifests through diverse symptoms, primarily encompassing neurocardiovascular issues like orthostatic intolerance and postural orthostatic tachycardia syndrome (POTS), as well as neurogastrointestinal disturbances [199]
Ensuring Trimix is used within its beyond-use date helps prevent these adverse effects
The severity of nausea may be reduced by starting with lower doses and gradually titrating upward, eating smaller meals, avoiding high-fat foods, and maintaining adequate hydration
Collagen synthesis and tissue remodeling are biological processes that take time
The use of substances to enhance some aspect of an individuals physical or emotional state is not a new phenomenon